APLS Apellis Pharmaceuticals Inc

$23.10

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 10/2/2025

About Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through inhibition of the complement system for autoimmune and inflammatory diseases. The company is headquartered in Waltham, Massachusetts.

Website: https://apellis.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1492422
Address
6400 WESTWIND WAY, SUITE A, CRESTWOOD, KY, US
Valuation
Market Cap
$2.28B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
10.00
Performance
EPS
$-1.60
Dividend Yield
Profit Margin
-25.30%
ROE
-93.50%
Technicals
50D MA
$24.37
200D MA
$30.88
52W High
$50.98
52W Low
$17.48
Fundamentals
Shares Outstanding
126M
Target Price
$42.35
Beta
0.84

APLS EPS Estimates vs Actual

Estimated
Actual

APLS News & Sentiment

Sep 26, 2025 • Benzinga NEUTRAL
Concentrix Posts Downbeat Earnings, Joins Legacy Education, Kingsoft Cloud And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Apellis Pharmaceuticals ( NASDAQ:APLS ) , Concentrix ( NASDAQ:CNXC )
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Friday. Shares of Concentrix Corporation ( NASDAQ: CNXC ) fell sharply in pre-market trading after the company reported worse-than-expected third-quarter adjusted EPS results and cut its FY25 adjusted EPS ...
Sep 26, 2025 • Benzinga NEUTRAL
Why Top KingWin Shares Are Trading Higher By 87%; Here Are 20 Stocks Moving Premarket - Apellis Pharmaceuticals ( NASDAQ:APLS )
Shares of Top KingWin Ltd ( NASDAQ: WAI ) rose sharply in pre-market trading after the company announced it entered into a sales contract with Walker Times International for the sale of 10,000 units of TK-D2C AI Robots. Top KingWin shares jumped 87.4% to $5.92 in the pre-market trading session.
Aug 27, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
WALTHAM, Mass., Aug. 27, 2025 ( GLOBE NEWSWIRE ) -- Apellis Pharmaceuticals, Inc. ( Nasdaq: APLS ) today announced that management will participate in webcast fireside chats at the following investor conferences: ...
Aug 27, 2025 • Benzinga SOMEWHAT-BULLISH
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences - Apellis Pharmaceuticals ( NASDAQ:APLS )
WALTHAM, Mass., Aug. 27, 2025 ( GLOBE NEWSWIRE ) -- Apellis Pharmaceuticals, Inc. APLS today announced that management will participate in webcast fireside chats at the following investor conferences: Wells Fargo Healthcare Conference Date/Time: Wednesday, September 3, 2025 at 8:45 a.m. ET
Jul 31, 2025 • Benzinga BULLISH
Roblox, Carvana, eBay, C.H. Robinson Worldwide, Huntington Ingalls Industries And Other Big Stocks Moving Higher On Thursday - Alnylam Pharmaceuticals ( NASDAQ:ALNY ) , AGCO ( NYSE:AGCO )
U.S. stocks were higher, with the Nasdaq Composite gaining around 150 points on Thursday. Shares of Roblox Corporation RBLX rose sharply during Thursday's session after the company reported better-than-expected second-quarter sales results and raised its FY25 sales guidance.
Jul 31, 2025 • GlobeNewswire NEUTRAL
Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results
WALTHAM, Mass., July 31, 2025 ( GLOBE NEWSWIRE ) -- Apellis Pharmaceuticals, Inc. ( Nasdaq: APLS ) , today announced its second quarter 2025 financial results and business highlights.
Sentiment Snapshot

Average Sentiment Score:

0.155
50 articles with scored sentiment

Overall Sentiment:

Bullish

APLS Reported Earnings

May 05, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $-0.54
  • Whisper:
  • Surprise %: 0.0%
Feb 25, 2025
Dec 31, 2024 (Pre market)
0.11 Surprise
  • Reported EPS: $-0.29
  • Estimate: $-0.40
  • Whisper:
  • Surprise %: 27.8%
Nov 05, 2024
Sep 30, 2024 (Pre market)
-0.16 Surprise
  • Reported EPS: $-0.46
  • Estimate: $-0.30
  • Whisper:
  • Surprise %: -54.1%
Aug 01, 2024
Jun 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $-0.28
  • Estimate: $-0.32
  • Whisper:
  • Surprise %: 12.5%
May 07, 2024
Mar 31, 2024 (Pre market)
0.05 Surprise
  • Reported EPS: $-0.42
  • Estimate: $-0.47
  • Whisper:
  • Surprise %: 10.6%
Feb 27, 2024
Dec 31, 2023 (Pre market)
-0.04 Surprise
  • Reported EPS: $-0.73
  • Estimate: $-0.69
  • Whisper:
  • Surprise %: -5.8%
Nov 01, 2023
Sep 30, 2023 (Pre market)
-0.31 Surprise
  • Reported EPS: $-1.17
  • Estimate: $-0.86
  • Whisper:
  • Surprise %: -36.0%
Jul 31, 2023
Jun 30, 2023 (Pre market)
0.3 Surprise
  • Reported EPS: $-1.02
  • Estimate: $-1.32
  • Whisper:
  • Surprise %: 22.7%
May 04, 2023
Mar 31, 2023 (Post market)
-0.1 Surprise
  • Reported EPS: $-1.56
  • Estimate: $-1.46
  • Whisper:
  • Surprise %: -6.8%

Financials